QLTY ETF Analysis: GMO U.S. Quality | NYSE
Large Blend | NYSE, USA | Market Cap: 5.080m USD | 12M Return: 25.3% | US90139K1007 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 13.0M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 2.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The GMO U.S. Quality ETF (QLTY) is an actively managed fund that invests primarily in U.S. equities that its adviser considers to be of high quality. The fund is overseen by Grantham, Mayo, Van Otterloo & Co. LLC (GMO), a Boston-based investment firm founded in 1977 and known for its asset allocation and quality-focused research approach.
Beyond common and preferred stocks, the fund may also hold convertibles, depositary receipts, equity REITs, income trusts, and shares of other equity-focused investment companies. Launched in November 2023 and classified in the Large Blend category, QLTY uses active security selection rather than passive index replication to pursue its quality objective.
- Quality factor outperforms amid market volatility and rate uncertainty
- ETF AUM growth driven by investor flight to defensive large-cap names
- Intense competition from rival quality ETFs pressures expense ratio margins
- Federal Reserve rate cuts shift investor preference toward high-quality balance sheets
As of August 15, 2026, the stock is trading at USD 43.25 with a total of 231,480 shares traded. Over the past week, the price has changed by +0.23%, over one month by +3.77%, over three months by +6.64% and over the past year by +25.25%.
Current recommended Stop Loss: 42.70 (which is 1.3% or 1.4 ATR below the current price).
GMO U.S. Quality has no consensus analysts rating.